Anesthesia-handover Checklist and Perioperative Outcomes in Elderly

November 27, 2024 updated by: Dong-Xin Wang, Peking University First Hospital

Impact of an Anesthesia-handover Checklist on Perioperative Outcomes of Elderly Patients Undergoing Major Noncardiac Surgery: A Prospective Before-and-after Study

With the increasing number of surgical cases, intraoperative handover of anesthesia care is common and inevitable. Verbal handover from one anesthesiologist to another during surgery are being used in many hospitals. However, verbal handover is often an informal, unstructured process during which omissions and errors can occur. It is possible that an improved anesthesia handover may reduce the related adverse events. This study aims to test the hypothesis that use of a well-designed, structured handover-checklist to improve handover quality may decrease the occurrence of postoperative complications in elderly patients undergoing major noncardiac surgery.

Study Overview

Detailed Description

It was estimated that more than 9 million patients undergo surgery with a complete anesthesia handover each year worldwide. Verbal handover from one anesthesiologist to another during surgery are being used in many hospitals; and there is no unified patient handover guideline at present.

It is well recognized that the transfer-of-care is a point of vulnerability where valuable patient information can be distorted and omitted. A previous study of the investigators showed that handover of anesthesia care was associated with a higher risk of delirium in elderly patients after major noncardiac surgery. The World Health Organization has included communication during patient care handovers among its top 5 patient safety initiatives.

It is possible that an improved anesthesia-handover protocol may reduce the related adverse events. Many efforts have performed to optimize handover processes. However, handover quality between anesthesiologists has rarely been investigated. The investigators hypothesize that a well-designed, structured handover-checklist will improve handover quality and reduce the occurrence of postoperative complications.

Study Type

Interventional

Enrollment (Actual)

1421

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100034
        • Peking University First Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Elderly patients (aged 65 years and over);
  2. Scheduled to undergo major non-cardiac surgery with an expected duration of at least 2 hours;
  3. Requirement of complete handover between anesthesiologists during surgery (initial anesthesiologist no longer returns).

Exclusion Criteria:

  1. Preoperative history of schizophrenia, epilepsy, Parkinsonism or myasthenia gravis;
  2. Inability to communicate before surgery (coma, profound dementia or language barrier);
  3. Craniocerebral injury or neurosurgery;
  4. Severe liver dysfunction (Child-Pugh grade C), severe renal dysfunction (requiring dialysis), or expected survival of <24 hours.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Pre-intervention
Anesthesia handover during surgery will be performed as usual, i.e., a verbal exchange of pertinent clinical information.
Anesthesia handover during surgery will be performed as usual, i.e., oral exchange of pertinent clinical information.
Experimental: Post-intervention
Anesthesia handover during surgery will be performed according to a structured checklist.
Anesthesia handover during surgery will be performed according to a structured handover checklist.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
A composite incidence of all complications within 30 days after surgery.
Time Frame: Up to 30 days after surgery.
Include organ injury (delirium, acute kidney injury, and myocardial injury) within 3 days and other major complications (class II or higher on Clavien-Dindo classification) within 30 days after surgery.
Up to 30 days after surgery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay in the intensive care unit after surgery.
Time Frame: Up to 30 days after surgery.
Length of stay in the intensive care unit after surgery.
Up to 30 days after surgery.
Intensive care unit admission after surgery.
Time Frame: Up to 30 days after surgery.
Intensive care unit admission after surgery.
Up to 30 days after surgery.
Incidence of organ injury (delirium, acute kidney injury, and acute myocardial injury) within 3 days after surgery.
Time Frame: Up to 3 days after surgery.
Delirium is diagnosed with the Confusion Assessment Method. Acute kidney injury is diagnosed according to the KDIGO (Kidney Disease: Improving Global Outcomes) Criteria. Acute myocardial injury is diagnosed according to the serum cardiac tropinin I level.
Up to 3 days after surgery.
Incidence of major complications within 30 days after surgery.
Time Frame: Up to 30 days after surgery.
Major complications are defined as newly occurred conditions that are harmful to patients' recovery and required medical therapy, i.e., class II or higher on the Clavien-Dindo classification.
Up to 30 days after surgery.
Length of hospital stay after surgery.
Time Frame: Up to 30 days after surgery.
Length of hospital stay after surgery.
Up to 30 days after surgery.
All-cause mortality within 30 days after surgery.
Time Frame: Up to 30 days after surgery.
All-cause mortality within 30 days after surgery.
Up to 30 days after surgery.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity within 3 days after surgery.
Time Frame: Up to 3 days after surgery.
Pain intensity is assessed with the Numeric Rating Scale, an 11-point scale where 0=no pain and 10=the worst pain.
Up to 3 days after surgery.
Subjective sleep quality within 3 days after surgery.
Time Frame: Up to 3 days after surgery.
Subjective sleep quality is assessed with the Numeric Rating Scale, an 11-point scale where 0=the best sleep and 10=the worst sleep.
Up to 3 days after surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dong-Xin Wang, MD, PhD, Peking University First Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 16, 2020

Primary Completion (Actual)

November 23, 2023

Study Completion (Actual)

December 23, 2023

Study Registration Dates

First Submitted

May 4, 2020

First Submitted That Met QC Criteria

May 4, 2020

First Posted (Actual)

May 6, 2020

Study Record Updates

Last Update Posted (Estimated)

December 2, 2024

Last Update Submitted That Met QC Criteria

November 27, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on Oral handover

Subscribe